Historical record - last NADAC effective date: 2/22/2017
Product Information
HYDROCHLOROTHIAZIDE 12.5 MG CP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0444 per EA under NDC 65862011399. Its NADAC has been published 170 times since Nov 28, 2013.
FDA first approved this application on Sep 18, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862011399
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/22/2017
Active Ingredients
HYDROCHLOROTHIAZIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078164FDA Approved
9/18/2007
TE Code
AB
On Market Since
9/19/2007
Pharmacological Classes
Price Statistics
The NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 18.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0444 per EA |
|---|---|
| All-time high | $0.0731 (Feb 12, 2014) |
| All-time low | $0.0424 (Jan 18, 2017) |
| Median price | $0.0535 |
| Average price | $0.0549 |
| Largest weekly change | +20.3% (Dec 18, 2013) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-18.5%
Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROCHLOROTHIAZIDE 12.5 MG CP?
The current National Average Drug Acquisition Cost (NADAC) for HYDROCHLOROTHIAZIDE 12.5 MG CP, manufactured by Aurobindo Pharma Limited, is $0.0444 per EA (NDC 65862011399), effective Feb 22, 2017.
How has the price of HYDROCHLOROTHIAZIDE 12.5 MG CP changed over time?
Over the history we have for it, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has declined 18.5%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for HYDROCHLOROTHIAZIDE 12.5 MG CP?
Since Nov 28, 2013, the NADAC for HYDROCHLOROTHIAZIDE 12.5 MG CP has ranged from a low of $0.0424 (Jan 18, 2017) to a high of $0.0731 (Feb 12, 2014), with a median of $0.0535 per EA.
Are there cheaper alternatives to HYDROCHLOROTHIAZIDE 12.5 MG CP?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HYDROCHLOROTHIAZIDE 12.5 MG CP, is $0.0279 per EA — about 37% below HYDROCHLOROTHIAZIDE 12.5 MG CP.
Who manufactures HYDROCHLOROTHIAZIDE 12.5 MG CP?
HYDROCHLOROTHIAZIDE 12.5 MG CP (NDC 65862011399) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.